Initial GT trials for ADA deficiency, performed already in early 1990, delivered the ADA gene into T lymphocytes or umbilical cord blood/bone marrow progenitor cells using the murine gamma-retroviral vector. This evidence concerns the gene ADA and hyperinsulinemic hypoglycemia, familial, 4.